-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psychiatric-readmissions_disposition-comments.pdf
May 21, 2015 - Use of claims data to examine the impact of length of
inpatient psychiatric stay on readmission rate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
June 12, 2012 - The provided forest plots don't support
the claims of statistically significant differences between
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth_research.pdf
January 01, 2020 - that favor interventions such as cesarean22
• Amplified perception of risk of medico-legal liability claims
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
January 30, 2014 - VU EPC DBD Protocol_AHRQ comments_revised_clean
Evidence-based Practice Center Systematic Review Protocol
Project Title: Psychosocial and Pharmacologic Interventions for Disruptive Behavior …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_disposition-comments.pdf
December 14, 2015 - Disposition of Comments for CER 157 Appendicitis
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Diagnosis of Right Lower Quadrant Pain and Suspected Acute
Appendicitis
Draft review available for public comment from November 4, 2014 to December 2, 2014.
Re…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
April 01, 2013 - Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: PCA3 Testing for the Diagnosis and Management of Prostate Cancer.
Draft review available for public comment from May …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
April 01, 2012 - Disposition of Comments for Treatment of Glaucoma: Comparative Effectiveness
Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1024
Published Online: April 2012
Comparative Effectiveness Research Review Disposition of Co…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
August 23, 2012 - Disposition of Comments Report for Nitrous Oxide for the Management of Labor Pain
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1175
Published Online: August 23, 2012
Comparative Effectiveness Research Review Disposition of Comments …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-adherence-interventions_executive.pdf
September 01, 2012 - All of the studies assessed medication
adherence using insurance claims data to measure either the
-
effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
January 01, 2018 - monitoring for AEs has been recommended
for several years,12,16,29 there is evidence from Medicaid
claims
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
May 01, 2014 - Clinician concerns about participation
• What knowledge is available from
various data sources (e.g., claims
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wiki-collaboration_research.pdf
September 01, 2011 - Feasibility Study of a Wiki Collaboration Platform for Systematic Reviews
Methods Research Report
Feasibility Study of a Wiki Collaboration Platform
for Systematic Reviews
Methods Research Report
Feasibility Study of a Wiki Collaboration Platform
for Systematic Re…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
November 01, 2013 - 1
Comparative Effectiveness Review
Number 126
Use of Natriuretic Peptide Measurement in the
Management of Heart Failure
Executive Summary
Background
Heart failure (HF) is a major concern
for health care systems because of its
chronic nature and resource implications.
HF affects approximately 5.7 million
Ameri…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments
Rapid Evidence Product
Adverse Events Associated With
COVID-19 Pharmaceutical Treatments
Background and Purpose
The purpose of this rapid review is to determine if COVID treatments authorized for
emergency use…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
November 01, 2013 - It summarizes and discusses the reviewer's analyses, the extent of evidence in
support of claims, and
-
effectivehealthcare.ahrq.gov/sites/default/files/nursing-home-safety_disposition-comments.pdf
May 27, 2016 - Peer reviewer #1 Background 13, 15: Claims provide littler basis for safety analyses.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
January 01, 2014 - not mean that those interventions do not work; rather there was not quality data to sustain such
claims
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-future_research.pdf
August 09, 2012 - The perceived risk of malpractice claims and lawsuits are thought to influence clinician behavior,
particularly
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
May 01, 2013 - Comment Response
Coyne, James Summary/Discussion/Conclusion [pg. 57]Applicability
Repeating the usual claims
-
effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
December 01, 2014 - intervals, to 20 mg, 40 mg, and up to the maximum recommended dose of 60
mg daily.58
The manufacturer claims